Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce D Wyse

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Journal of Pain (London, England)|September 11, 2007
Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanolIrina Vetter, Bruce D Wyse, Sarah J Roberts-Thomson, et al.
Molecular Pain|July 18, 2006
The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathwayIrina Vetter, Bruce D Wyse, Gregory R Monteith, et al.
Journal of Medicinal Chemistry|June 12, 2012
Synthesis and biological evaluation of an orally active glycosylated endomorphin-1Pegah Varamini, Friederike M Mansfeld, Joanne T Blanchfield, et al.
Behavioural Pharmacology|February 15, 2014
Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathyMaree T Smith, Tanya Lau, Victoria C J Wallace, et al.
Journal of Pharmaceutical Sciences|May 22, 2015
Topical application of a novel oxycodone gel formulation (tocopheryl phosphate mixture) in a rat model of peripheral inflammatory pain produces localized pain relief without significant systemic exposureMaree T Smith, Bruce D Wyse, Stephen R Edwards, et al.
Plos One|August 23, 2012
Lipo-endomorphin-1 derivatives with systemic activity against neuropathic pain without producing constipationPegah Varamini, Friederike M Mansfeld, Joanne T Blanchfield, et al.
Bioorganic & Medicinal Chemistry|February 26, 2013
Peripherally acting novel lipo-endomorphin-1 peptides in neuropathic pain without producing constipationPegah Varamini, Wei Huang Goh, Friederike M Mansfeld, et al.
The Journal of Biological Chemistry|May 17, 2008
Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitizationIrina Vetter, Wei Cheng, Madusha Peiris, et al.
The Journal of Biological Chemistry|April 15, 2003
Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membraneBruce D Wyse, Ian A Prior, Hongwei Qian, et al.
Bioorganic & Medicinal Chemistry|March 12, 2014
Endomorphin analogues with mixed μ-opioid (MOP) receptor agonism/δ-opioid (DOP) receptor antagonism and lacking β-arrestin2 recruitment activityJun Cai, Bowen Song, Yunxin Cai, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Journal of Pain (London, England)|September 11, 2007
Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanolIrina Vetter, Bruce D Wyse, Sarah J Roberts-Thomson, et al.
Molecular Pain|July 18, 2006
The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathwayIrina Vetter, Bruce D Wyse, Gregory R Monteith, et al.
Journal of Medicinal Chemistry|June 12, 2012
Synthesis and biological evaluation of an orally active glycosylated endomorphin-1Pegah Varamini, Friederike M Mansfeld, Joanne T Blanchfield, et al.
Behavioural Pharmacology|February 15, 2014
Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathyMaree T Smith, Tanya Lau, Victoria C J Wallace, et al.
Journal of Pharmaceutical Sciences|May 22, 2015
Topical application of a novel oxycodone gel formulation (tocopheryl phosphate mixture) in a rat model of peripheral inflammatory pain produces localized pain relief without significant systemic exposureMaree T Smith, Bruce D Wyse, Stephen R Edwards, et al.
Plos One|August 23, 2012
Lipo-endomorphin-1 derivatives with systemic activity against neuropathic pain without producing constipationPegah Varamini, Friederike M Mansfeld, Joanne T Blanchfield, et al.
Bioorganic & Medicinal Chemistry|February 26, 2013
Peripherally acting novel lipo-endomorphin-1 peptides in neuropathic pain without producing constipationPegah Varamini, Wei Huang Goh, Friederike M Mansfeld, et al.
The Journal of Biological Chemistry|May 17, 2008
Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitizationIrina Vetter, Wei Cheng, Madusha Peiris, et al.
The Journal of Biological Chemistry|April 15, 2003
Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membraneBruce D Wyse, Ian A Prior, Hongwei Qian, et al.
Bioorganic & Medicinal Chemistry|March 12, 2014
Endomorphin analogues with mixed μ-opioid (MOP) receptor agonism/δ-opioid (DOP) receptor antagonism and lacking β-arrestin2 recruitment activityJun Cai, Bowen Song, Yunxin Cai, et al.
Pageof 2